GSCA analysis found that the expressions of CEP55, CCNB1, CDK1 and TRIP13 were significantly increased in stage II of CRC, therefore, these genes, especially CEP55, may be related to the development and proliferation of early CRC. This evidence concerns the gene TRIP13 and colorectal carcinoma.